Traws Pharma, Inc. · NASDAQ:TRAW

Orbimed Advisors LLC reported a 11.90% stake in Traws Pharma, Inc. (Schedule 13D/A)

Event Apr 16, 2026 · Filed May 5, 2026

Orbimed Advisors LLC reported a 11.90% stake in Traws Pharma, Inc., 1,876,198 shares, with active intent on Apr 16, 2026. Filed May 5, 2026 (Schedule 13D/A).

Stake
11.90%
Shares
1,876,198
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC11.90%1,876,198
OrbiMed Capital GP VIII LLC11.90%1,876,198

Source

View original at SEC

Related